Does wearing two masks provide more protection?
It depends, but it’s possible that doubling up could help in some situations.
The U.S. Centers for Disease Control and Prevention recommends wearing a cloth mask made with two or more layers, and ensuring it covers your nose and mouth. The agency says it should fit snugly so there aren't any gaps at the sides of your face.
Wearing just one mask should be enough for most situations, as long as it fits well and isn't loose, said Dr. David Hamer, an infectious disease expert at Boston University.
“Starting out with a good mask to begin with is going to be key,” Hamer said.
Still, some people might want extra protection if they're at risk for severe illness if infected or will be in situations where they expect to be around others for extended periods, such as on a plane.
One option in scenarios when you want extra protection is to wear a cloth mask as well as a regular surgical mask, said Dr. Monica Gandhi, an infectious disease expert at the University of California, San Francisco.
Gandhi said that combination -- with either mask on top -- could help achieve a similar effect as the N95 mask. She recommended the added protection for people who will be indoors in areas where transmission rates are high — which could reflect the circulation of more contagious variants.
Another option Gandhi and a colleague recommend for situations where you want “maximum” protection: A two-layer cloth mask that has a filter material in between.
With single cloth masks for everyday use, Gandhi noted it's important that they're made of tightly-woven material and have at least two layers, which creates “an obstacle course” that makes it harder for virus-carrying particles to break through.
The sophisticated rocket sent a payload that included 24 satellites, a new, solar-powered space sail, and the ashes of 152 people, into space with its side boosters successfully returning to Earth unscathed.
That next step for meat alternatives will apparently include fish as companies like Wild Type, BlueNalu, and Finless Foods wager that, in the age of plant-based burgers, there’s room for seafood grown in the lab.
These are the headlines you Need 2 Know for Wednesday, June 19, 2019.
Elon Musk may be going to Vegas. The Las Vegas Convention and Visitors Authority has recommended that The Boring Company be chosen to construct a "people mover" below the expanding convention center.
Cannabis, hemp, reefer, marijuana, dope, pot, grass ー no matter what term you choose, they all refer to the same plant: cannabis sativa. It’s a common misconception that cannabis sativa exclusively means that particular strain of weed that makes you creative and focused (as opposed to indica, which promotes relaxation)ー but it’s actually the scientific name of the single plant that yields marijuana, CBD, and hemp, among other products.
These are the headlines you Need 2 Know for Tuesday, Feb. 19, 2019.
Canopy Growth CEO Bruce Linton won't guarantee investors dividends. What he will promise is a stake in global cannabis domination. "If people want a dividend, we are probably not the right stock. If they want some entity aimed at dominating a global opportunity that started in Canada, we are probably your best bet," Linton told Cheddar on Friday, one day after the company reported a massive spike in third-quarter revenue.
These are the headlines you Need 2 Know for Friday, Feb, 15, 2019.
It's a big week in cannabis earnings ー Aurora Cannabis reported Monday and Canopy Growth will report Thursday ー but Paul Rosen, CEO of cannabis private equity firm Tidal Royalty, said he's noticing a concerning trend."All the companies are facing gross margin compression because there are excise taxes, there's a massive marketing spend as we go to recreational cannabis, and there's also increased packaging costs. So I think you're going to see a trend line here, which is revenue and capacity going up, but gross margin is going down," Rosen told Cheddar Wednesday.
Opiant Pharmaceuticals, the developer of opioid antidote NARCAN, is in the process of developing a version of its lifesaving drug for cannabanoid overdoses, the company's CEO told Cheddar in an interview on Wednesday.
